- Report
- July 2025
- 375 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 383 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 141 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 565 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 170 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 387 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 392 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 166 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 244 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 193 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 197 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- July 2025
- 371 Pages
Global
From €5158EUR$5,850USD£4,477GBP
- Report
- November 2024
- 180 Pages
Global
From €3372EUR$3,825USD£2,927GBP
€3968EUR$4,500USD£3,444GBP
- Report
- May 2025
- 110 Pages
Global
From €4188EUR$4,750USD£3,635GBP
- Report
- December 2024
- 200 Pages
Global
From €3306EUR$3,750USD£2,870GBP
- Report
- June 2025
- 400 Pages
Global
From €4363EUR$4,949USD£3,787GBP
- Report
- May 2025
- 150 Pages
Global
From €4276EUR$4,850USD£3,711GBP
- Report
- April 2025
- 150 Pages
Global
From €2865EUR$3,250USD£2,487GBP
€4276EUR$4,850USD£3,711GBP
- Report
- November 2024
- 150 Pages
Global
From €2865EUR$3,250USD£2,487GBP
€4276EUR$4,850USD£3,711GBP
- Report
- September 2024
- 150 Pages
Global
From €2865EUR$3,250USD£2,487GBP
€4276EUR$4,850USD£3,711GBP

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more